Phase II Study of Cyclophosphamide, Epirubicin, Vincristine, Prednisone, and Etoposide (CEOP-E) for Aggressive Non-Hodgkin's Lymphoma

The main objectives of the current study were to evaluate the efficacy and safety of a CEOP-E regimen for patients with aggressive non-Hodgkin's lymphoma (NHL). Fifty-one consecutive patients with newly diagnosed aggressive NHL were enrolled in the study. Median age of patients was 57 (range, 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jong Gwang, Sohn, Sang Kyun, Kim, Dong Hwan, Baek, Jin Ho, Park, Tae In, Lee, Kyu Bo
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2004
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816291/
https://www.ncbi.nlm.nih.gov/pubmed/15608392
http://dx.doi.org/10.3346/jkms.2004.19.6.820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816291/
https://www.ncbi.nlm.nih.gov/pubmed/15608392
http://dx.doi.org/10.3346/jkms.2004.19.6.820

Ejemplares similares